GGrantIndex
Sort

17,828 grants matching crispr

Mapping, programming, and correcting gene regulatory sequences for Alagille Syndrome

$761,891
Jesse M Engreitz · Stanford University · R01 · FY2025 · HL

Microglia, HIV and drugs of abuse

$761,883
Brandon Harvey · National Institute On Drug Abuse · ZIA · FY2023 · DA

Integrative genomics to map risk genes and pathways in autism and epilepsy

$761,831
Dalila Pinto · Icahn School Of Medicine At Mount Sinai · R01 · FY2019 · MH

Integrative genomics to map risk genes and pathways in autism and epilepsy

$761,831
Dalila Pinto · Icahn School Of Medicine At Mount Sinai · R01 · FY2020 · MH

Studies of gene fusions in rhabdomyosarcoma

$761,828
Frederic Barr · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA

Programmed Cell Death In The Nervous System

$761,621
Richard Youle · National Institute Of Neurological Disorders And Stroke · ZIA · FY2020 · NS

Integrative genomics to map risk genes and pathways in autism and epilepsy

$761,601
Dalila Pinto · Icahn School Of Medicine At Mount Sinai · R01 · FY2017 · MH

In Vivo RNA-Mediated Gene Editing of Hemophilia A

$761,424
Drew Weissman · University Of Pennsylvania · R01 · FY2017 · HL

Unraveling the Genetic Programs Engaged in ASD Neurons Through Coupled Transcriptomic and Phenotypic Readouts

$761,381
Samouil Farhi · Broad Institute, Inc. · R01 · FY2022 · MH

Mechanisms of transcriptional regulation of ccr5 and host genetic control of HIV

$761,312
Richard E. Sutton · Yale University · R01 · FY2020 · AI

Mechanisms of Cardiac Myosin Heavy Chain Gene Regulation

$761,152
Neil C Chi · University Of California, San Diego · R01 · FY2025 · HL

Integrative genomics to map risk genes and pathways in autism and epilepsy

$760,914
Dalila Pinto · Icahn School Of Medicine At Mount Sinai · R01 · FY2018 · MH

Role of Natural Killer Cell Diversity in Multiple Sclerosis Risk and Disease Course

$760,808
Jill Allison Hollenbach · University Of California, San Francisco · R01 · FY2023 · AI

Investigation of an RNA topoisomerase complex involved in Fragile X syndrome

$760,486
Weidong Wang · National Institute On Aging · ZIA · FY2016 · AG

Chemotherapy-free cure of hemoglobin disorders through base editing

$760,457
Daniel Evan Bauer · Boston Children'S Hospital · R01 · FY2024 · HL

In utero gene editing to cure a metabolic liver disease

$760,313
William H. Peranteau · Children'S Hosp Of Philadelphia · R01 · FY2020 · DK

Genomic characterization and development of therapies for pediatric sarcoma

$760,170
John Shern · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA

Transcriptional regulation of chamber selective gene expression

$760,112
William T Pu · Boston Children'S Hospital · R01 · FY2025 · HL

Uncovering colorectal cancer etiology and biology by integrating proteomics with other omics data

$760,042
Xingyi Guo · Vanderbilt University Medical Center · R01 · FY2023 · CA

Omics, mice, and men: Development of precision transfusion medicine

$759,990
Mark Thomas Gladwin · University Of Pittsburgh At Pittsburgh · R01 · FY2019 · HL

Therapy Development for Genetic Disorders of the RAS/MAPK Pathway

$759,920
Bruce D Gelb · Icahn School Of Medicine At Mount Sinai · R01 · FY2024 · HL

Defining gene regulatory networks driving cortical evolution and brain development

$759,494
Luis De La Torre-Ubieta · University Of California Los Angeles · R01 · FY2021 · MH

Integrative Genomic Analyses of Macrophages in Crohns Disease

$759,420
Judy H Cho · Icahn School Of Medicine At Mount Sinai · R01 · FY2019 · DK

Integrative Genomic Analyses of Macrophages in Crohns Disease

$759,420
Judy H Cho · Icahn School Of Medicine At Mount Sinai · R01 · FY2020 · DK

Integrative Genomic Analyses of Macrophages in Crohns Disease

$759,420
Judy H Cho · Icahn School Of Medicine At Mount Sinai · R01 · FY2017 · DK